Viking Therapeutics, Inc. (VKTX) Operating Income (Loss) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Viking Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • Viking Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$34.1 M, a 65.9% decline year-over-year.
  • Viking Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$114 M, a 53.2% decline year-over-year.
  • Viking Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$101 M, a 43.3% decline from 2022.
  • Viking Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$70.4 M, a 26.4% decline from 2021.
  • Viking Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$55.7 M, a 30.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$114 M -$34.1 M -$13.5 M -65.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$101 M -$29.3 M -$9 M -44.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 -$91.8 M -$27.3 M -$11.1 M -68.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-25
Q2 2023 -$80.8 M -$23.7 M -$6.11 M -34.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-26
Q1 2023 -$74.6 M -$20.5 M -$4.29 M -26.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$70.4 M -$20.3 M -$7.77 M -62.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 -$62.6 M -$16.2 M -$2.79 M -20.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-25
Q2 2022 -$59.8 M -$17.6 M -$2.09 M -13.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-26
Q1 2022 -$57.7 M -$16.2 M -$2.02 M -14.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 -$55.7 M -$12.5 M -$1.25 M -11.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 -$54.4 M -$13.4 M -$3.56 M -36.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 -$50.9 M -$15.5 M -$4.94 M -46.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 -$45.9 M -$14.2 M -$3.28 M -30% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 -$42.7 M -$11.3 M -$2.39 M -27% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-09
Q3 2020 -$40.3 M -$9.84 M -$2.4 M -32.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$37.9 M -$10.6 M -$1.04 M -10.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 -$36.8 M -$10.9 M -$4.14 M -60.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 -$32.7 M -$8.87 M -$1.84 M -26.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-17
Q3 2019 -$30.9 M -$7.44 M -$45 K -0.61% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 -$30.8 M -$9.57 M -$2.64 M -38.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 -$28.2 M -$6.81 M -$2 M -41.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 -$26.2 M -$7.04 M -$2.61 M -59% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$23.6 M -$7.39 M -$2.7 M -57.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$20.8 M -$6.93 M -$1.94 M -39% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$18.9 M -$4.81 M +$164 K +3.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$19.1 M -$4.43 M -$688 K -18.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$18.4 M -$4.69 M -$1.43 M -43.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$17 M -$4.98 M -$1.4 M -39.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$15.5 M -$4.97 M -$1.7 M -52.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$13.8 M -$3.74 M +$883 K +19.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$14.7 M -$3.26 M +$1.02 M +23.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$15.8 M -$3.58 M -$951 K -36.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$14.8 M -$3.27 M -$2.81 M -609% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$12 M -$4.62 M -$4.27 M -1207% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-21
Q3 2015 -$7.73 M -$4.29 M -$3.14 M -273% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$4.59 M -$2.63 M +$19.1 M +87.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$23.7 M -$461 K -$251 K -120% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$23.5 M -$354 K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$1.15 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$21.8 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$210 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-06-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.